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Multipotent cells from the juvenile subventricular zone (SVZ) possess the ability to differ-
entiate into new neural cells. Depending on local signals, SVZ can generate new neurons,
astrocytes, or oligodendrocytes. We previously demonstrated that activation of NMDA
receptors in SVZ progenitors increases the rate of oligodendrocyte differentiation. Here we
investigated the mechanisms involved in NMDA receptor-dependent differentiation. Using
functional studies performed with the reporter gene luciferase we found that activation
of NMDA receptor stimulates PKC. In turn, stimulation of PKC precedes the activation
of NADPH oxidase (NOX) as demonstrated by translocation of the p67phox subunit to
the cellular membrane. We propose that NOX2 is involved in the transduction of the
signal from NMDA receptors through PKC activation as the inhibitor gp91 reduced their
pro-differentiation effect. In addition, our data and that from other groups suggest that
signaling through the NMDA receptor/PKC/NOX2 cascade generates ROS that activate the
PI3/mTOR pathway and ﬁnally leads to the generation of new oligodendrocytes.
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INTRODUCTION
Extracellular glutamate is one of the most important neuro-
transmitters and neuromodulators of the CNS. It participates in
different functions such as synaptic plasticity, LTP and learn-
ing, glia-neuron communication, or transduction of sensory
input at the periphery and nociceptive pathway (for a review, see
Fellin and Carmignoto, 2004; Carozzi et al., 2008; Niswender and
Conn, 2010). In addition, at high concentrations glutamate can
contribute to excitotoxicity and apoptotic cell death. Glutamate
exerts its function through two different subfamily of receptors,
metabotropic and ionotropic, which are expressed in neurons,
astrocytes, and oligodendrocytes as well (Matute et al., 2006;
Matute, 2011a,b), but less is known about its role in modulating
adult neurogenesis and gliogenesis.
Extracellular glutamate activates various ionotropic recep-
tors. Depending on their molecular structure and pharmacology,
they can be divided in AMPA (GluA1–GluA4), kainate (GluK1–
GluK5), NMDA (GluN1, GluN2A–GluN2D, GluN3A-B) receptor
subtypes. The receptors are heteromers and form ion channels,
with fast response times, and generate an overall increase in
Ca++ along with inﬂux of Na+. All functional NMDA recep-
tors have the GluN1 subunit associated with other subunits.
Moreover, NMDA receptor activation requires the co-activation
of glycine (Kleckner and Dingledine, 1988), and the receptors
bearing GluN3 subunits bear more afﬁnity for this amino acid
(Yao and Mayer, 2006).
Excessive stimulation of ionotropic glutamate receptors can
trigger excitotoxic cell death (Matute, 2011b). For this reason the
pharmacology of ionotropic glutamate receptors is important to
develop new drugs for the treatment of neurological disorders
such as brain ischemia, epilepsy, and more recently demyelinating
diseases (Kim et al., 2011).
Depending on the stage of maturation, oligodendrocyte pre-
cursor cells (OPCs) and mature oligodendrocytes possess vari-
ous combinations of glutamate receptor subtypes. Metabotropic
receptors are highly expressed in OPCs but less in mature oligo-
dendrocytes. This also would explain the higher sensitivity of
OPCs to hypoxia with respect to mature oligodendrocytes (Deng
et al., 2004). All mGluRs are expressed in OPCs but only recep-
tors in group I are able to protect OPCs from excitotoxic death,
by preventing ROS generation (Deng et al., 2004; Luyt et al.,
2006). In turn, activation of mGluR can counteract the effects
of NMDA receptors in oligodendrocyte differentiation (Cavaliere
et al., 2012).
The exact role of NMDA receptors during oligodendrocyte
maturation is unclear (Matute et al., 2006; Cavaliere et al., 2012).
There is evidence suggesting that NMDA receptor signaling in
oligodendrocyte progenitors is not required for oligodendrogene-
sis and myelination (De Biase et al., 2011). Thus, genetic deletion
of structural GluN1 from OPCs does not result in changes in
proliferation, differentiation, or myelination. More recently, we
observed that strong activation of NMDA receptors in oligoden-
drocytes precursor cells derived from subventricular zone (SVZ)
multipotent cells increases their differentiation and myelination
rate in vitro. This datawas conﬁrmedusingNMDAreceptor antag-
onists or speciﬁc knockdown of GluN1 by RNA interference in
OPCswhich prevented differentiation induced byNMDA(Li et al.,
2013).
Here we studied the intracellular pathway primed by NMDA
receptor activation leading to oligodendrocyte differentiation in
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a culture of rat SVZ neurospheres. We observed that activation
of NMDA receptors stimulates differentiation via PKC/NADPH
oxidase (NOX)-dependent ROS generation.
MATERIALS AND METHODS
NEUROSPHERE CULTURE
Cultures were prepared from 4 to 7-day-old Sprague-Dawley rat
pups. The SVZ was isolated and minced with a McIllwain tis-
sue chopper. SVZ tissue from two to three brains was digested
for 10 min at 37◦C in 5 ml of trypsin/EDTA (Sigma, Madrid,
Spain). Digestion was stopped by adding an equal volume of
trypsin inhibitor and 0.01% DNAse I (both from Sigma, Madrid,
Spain) for 5 min at room temperature. The cell suspension was
centrifuged for 10 min at 600 × g and the pellet mechani-
cally dissociated 25 times in NeuroCult medium (Stem Cell Inc.,
Grenoble, France) using a glass Pasteur pipette and 20 times
using 1 ml pipette tips. The cells that remained in suspension
were decanted and the single cell suspension counted using the
Neubauer method. Cells were seeded in proliferation medium
(NeuroCult with 10% neural stem cell factors from Stem Cell
Inc., 2 mM glutamine, penicillin/streptomycin mix, 20 ng/ml EGF
(Promega, Madrid, Spain), 10 ng/ml bFGF (Promega), 10 ng/ml
PEDF (Millipore, Madrid, Spain) at a density of 104 cells/cm2 and
cultivated in suspension for 7 days at 37◦C, 5% CO2. EGF, bFGF,
and PEDF were added fresh every 2–3 days.
OLIGODENDROCYTE DIFFERENTIATION
After 7 DIV (days in vitro), cells were aggregated as neurospheres.
The neurospheres were maintained for 3 days in oligodendro-
cyte differentiation medium (ODM) composed of DMEM with
4.5 mg/ml glucose and sodium pyruvate (Gibco, Barcelona,
Spain), SATO (100 μg/ml BSA, 100 μg/ml transferrin, 16 μg/ml
putrescine, 40 ng/ml thyroxine, 30 ng/ml tri-iodothryronine,
60 ng/ml progesterone, 40 ng/ml selenium, all of from Sigma),
6.3 mg/ml N-acetyl-cysteine (Sigma), 0.5 mg/ml insulin (Sigma),
1 μg/ml CNTF (Peprotech, London, UK), and 10 μg/ml NT3
(Peprotech). This step was considered to be the pre-commitment
stage before oligodendrocyte differentiation. After 3 DIV, ﬂoating
FIGURE 1 | Activation of NMDA receptors in neurospheres induces PKC
activation and oligodendrocyte differentiation.(A) Pre-differentiated
neurospheres were dissociated and transfected with 3 μg of pAP1-
LightSwitch. Cells were differentiated for 12 h in the presence of 100 μM
NMDA or 100 nM G0 6893. Empty vector, without AP1 promoter, was
transfected as a negative control. (B) Neurospheres were differentiated to
oligodendrocyte for 3–5 days in the presence of 100 μM NMDA, 100 nM
G0 6983, or 10 nM PMA. Cells were ﬁxed, immunostained with anti-MBP
(red) and counterstained with DAPI (blue; left panel). Differentiation was
evaluated as the ratio between MBP positive cells vs. total cells
counterstained with DAPI and expressed as a fold increase respect to the
control (bar graph). Counts represent means ± SEM (n = 4 independent
experiments, ﬁve ﬁelds in each). ***p < 0.001, **p < 0.01 and *p < 0.005
vs. CTRL, ##p < 0.01 vs. 100 μM NMDA. Scale bar = 100 μm.
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neurospheres were allowed to attach to cover slips previously
treated with poly-ornithine in ODM and differentiated for 1–10
DIV in the presence of different compounds (G0 6983 from Tocris,
Madrid, Spain; gp91 from Anaspec, Liege, Belgium). Differenti-
ation was evaluated by immunoﬂuorescence as a ratio of myelin
basic protein (MBP, from R&D System, Madrid, Spain; used at
1:1000) positive cells determined by immunoﬂuorescence to total
nuclei determined by staining with DAPI. All experiments with
NMDA were performed in the presence of 100 μM glycine.
ANIMAL CARE
All experiments were approved by the local Animal Care Com-
mittee of the University of Basque Country (Spain) Animal Ethics
committee, as relevant, following European Communities Coun-
cil Directive of 22 September 2010 (2010/63/EU). Every possible
effort was made to minimize animal suffering and the number of
animals used.
IMMUNOCYTOCHEMISTRY
Cell cultures on cover slipswere ﬁxed in 4%paraformaldehyde and
permeabilized with 0.05% Triton and 5% normal goat serum in
phosphate-buffered saline (PBS). Cells were incubated with MBP
primary antibody at 1:1000 dilution for 2 h at room tempera-
ture and then washed three times with 0.05% Triton in PBS. All
secondary antibodies at 1:200 were added and incubated for 1 h
in the dark at room temperature (Molecular Probes, Barcelona,
Spain). After three washes with 0.05% Triton in PBS, cells cultures
were stained for 1min at room temperaturewithDAPI and further
washed with PBS. Finally, cover slips were mounted with Glycergel
(Dako, Barcelona, Spain) and examined by ﬂuorescence using the
Apotome system (Zeiss, Goettingen, Germany).
mRNA EXTRACTION AND QUANTITATIVE RT-PCR
Total RNA from neurospheres (approximately 5000 neurospheres)
after pre-differentiation was extracted with a commercial kit
(Life technologies-Ambion, Madrid, Spain). The quality of the
total RNA was determined by agarose gel electrophoresis and
1 μg was reverse transcribed at 60◦C for 60 min using Super-
script SSIII (Invitrogen, Madrid, Spain). A 2 μl aliquot of each
mRNA were used for real-time quantitative PCR. Primers spe-
ciﬁc for rat NOX1, NOX2, and NOX3 were designed having
the following sequence; NOX1fwd: TAC GAA GTG GCT GTA
CTG GTT G, NOX1rev: CTC CCA AAG GAG GTT TTC TGT;
NOX2fwd: GGT TCC AGT GCG TGT TGC T, NOX2rev: TCT
TAT GGA AAG TAA GGT TCC TGT CC; NOX4fwd: GGA AGT
CCA TTT GAG GAG TCA T, NOX4rev: TGG ATG TTC ACA
AAG TCA GGT C. GAPDH and Hprt1 primers were used for
normalization and the standard curves were determined using
PrimerExpress software (Applied Biosystems, Madrid, Spain).
Real-time quantitative PCR reactions were performed for 40 cycles
at 60◦C in a BioRadCFX96 ampliﬁcation system (BioRad,Madrid,
Spain).
LUMINESCENT ASSAY FOR PKC ACTIVITY
Pre-differentiated neurospheres were disgregated with Accu-
tase (Sigma) and transfected by electroporation (Amaxa-Lonza,
Madrid, Spain) with 3 μg of the plasmid pAP1-LightSwitch
(SwitchGear genomics, Menlo Park, CA, USA). Cells were
lysed at different times in the presence of the substrate for
luciferase Luminescence produced by the luciferase reaction
(luciferin + ATP + luciferase −→ AMP+light) was quantiﬁed
with a luminometer (Sinergy HT by Biotek, Potton, Bedfordshire,
UK)
STATISTICAL ANALYSIS
Data are presented asmeans± SEM. Statistical analysis was carried
out with the Student t test and, in all instances, at least a value of
p < 0.05 was considered signiﬁcant.
RESULTS
Ourprevious results demonstrated that overstimulation of NMDA
receptors of SVZ multipotent cells induced an increase of oligo-
dendrocyte differentiation through NOX-dependent generation
of ROS (Cavaliere et al., 2012). Here we hypothesize that NOX
activation is induced by PKC activation. After proliferation and
the pre-differentiation protocol (see Materials and Methods)
we transfected pre-differentiated neurospheres with a plasmid
(pLightSwitch) carrying the reporter gene luciferase under the
control of the PKC-activated promoter AP1. In cells transfected
with pLightSwitch, if PKC becomes activated, expression from
the AP1 promoter increases which results in increased luciferase
activity. PKC activity can therefore be registered by monitor-
ing luminescence intensity after the reaction with the substrate,
luciferin. On monitoring luciferase activity over a time course
of 12, 24, and 72 h after differentiation, we detected a maximal
PKC activity at 12 h post transfection (data not shown). At this
time point the treatment of neurospheres with 100 μM NMDA
during differentiation increased the basal level of PKC activity
by 2.15-fold (Figure 1A), while NMDA treatment in the pres-
ence of the PKC inhibitor G0 6983 almost completely inhibited its
activity. To conﬁrm the involvement of PKC in NMDA mediated
oligodendrocyte differentiation we counted the number of MBP+
FIGURE 2 | Neurosphere cultures were differentiated for 3 days in the
absence (CTRL) or presence of 100 μM NMDA. After 2 days, proliferating
cells were primed with 10 μM BrdU for 24 h, ﬁxed and stained with
markers to label mature oligodendrocyte (O4), OPC (PDGFR/O4),
astrocytes (GFAP+/BrdU−), neurons (βIII tubulin), and total proliferating
cells (BrdU). Results are expressed as a percentage of stained cells vs.
total cells, counterstained with DAPI. Counts represent means ± SEM
(n = 3 independent experiments, ﬁve ﬁelds in each). ∗∗p < 0.01, ∗p < 0.05
vs. CTRL.
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FIGURE 3 | (A) cDNA from pre-differentiated neurospheres was analyzed
by quantitative RT-PCR with primers for NOX1–2 and 4. Quantiﬁcation
was calculated as Dct relative values. Bar graphs represent the
mean of four different experiments. (B) Neurospheres were
differentiated to oligodendrocyte for three days in the presence of
100 μM NMDA and 50 μM MK801. Cells were ﬁxed, immunostained
with O4 (red) and p67phox (green). Bar = 5 μm. Analysis of
colocalization shown on the right graphs was performed by the
“Linescan” application of the LAS-AF software (Leica). Red and green
peaks, belonging to O4 and p67 signal respectively, colocalized only in
the NMDA treated cell, whereas in CTRL and NMDA+MK801 the p67
green signal is more dispersed along the cell body (black bar). White
arrows point at cellular membrane sites corresponding to black arrows
on the Linescan.
cells vs. the total cells counterstained with DAPI in the presence
of NMDA alone or in conjunction with G0 6983. As previously
observed (Cavaliere et al., 2012),NMDA stimulation increased the
differentiation rate by 30%, and this effect was blocked by the
PKC inhibitor G0 6983. As a positive control of PKC-dependent
differentiation we used the PKC activator phorbol 12-myristate
13-acetate (PMA), which increased the basal differentiation by
nearly 50% (Figure 1B).
In addition, we evaluated the effect of NMDA stimulation
on the differentiation of neurons and astrocytes, as well as on
the proportion of OPCs that did not differentiate into mature
oligodendrocytes. Cell cultures were stained after 3 days of differ-
entiation with antibodies to PDGF receptor (PDGFR), to label
only OPCs and with O4 that label both OPCs and mature
oligodendrocytes. Mature oligodendrocytes were only positive
for O4 whereas OPCs were positive for both markers. Treat-
ment of cells with NMDA during differentiation induced an
increase in the number of differentiated oligodendrocyte, but a
signiﬁcative reduction on the OPCs number (Figure 2), demon-
strating the effect of NMDA on differentiation from immature
to mature oligodendrocyte. To evaluate astrocyte differentiation
we labeled the proliferating cells with 10 μM BrdU and stained
the cultures with anti-GFAP and anti-BrdU antibodies. GFAP is
expressed in both proliferating SVZ progenitor cells and in non-
proliferating mature astrocytes.To quantify mature astrocytes we
counted only GFAP+/BrdU− cells. No signiﬁcant differences were
found between control and NMDA treated cells. Likewise, no
differences were found on the number of differentiated neurons
as assessed with βIII tubulin staining, or in the total number of
proliferating cells (BrdU+ cells; Figure 2).
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In a previous study we demonstrated that NMDA-dependent
oligodendrocyte differentiation occurred through the activation of
NOX and the subsequent generation of intracellular ROS, which
acted as a second messenger (Cavaliere et al., 2012). To estab-
lish the link between NMDA receptors, PKC and NOX activation,
we ﬁrst examined the expression proﬁles of the transcripts that
encode the various NOXs expressed in the CNS (NOX1–2, 4)
by quantitative RT-PCR. We found that all the NOXs examined
are expressed in SVZ multipotent cells (Figure 3A). Furthermore,
we observed that stimulation with NMDA (100 μM) during dif-
ferentiation induced the traslocation of NOX subunit p67phox
into the oligodendrocyte plasma membrane (Bedard and Krause,
2007), as demonstrated by confocal double immunoﬂuorescence
with O4 (Figure 3B). The use of the speciﬁc NMDA antagonist
MK801 modulated the translocation, demonstrating the speci-
ﬁcity of the NMDA effect. To get some insight as to which of
the NOXs is involved in the modulation of oligodendrocyte dif-
ferentiation we measured the differentiation rate after treatment
of cells with NOX inhibitors. Gp91, which speciﬁcally inhibits
NOX2, reverted the effect of NMDA during differentiation by
70% suggesting a pivotal role for NOX2 in oligodendrocyte dif-
ferentiation (Figure 4A). The other general inhibitor, DPI, was
toxic to the cells (data not shown). Finally, to further assess
the involvement of the NMDA-PKC-NOX signaling cascade in
modulating differentiation, we measured ROS generation during
differentiation after stimulation with NMDA. We observed that
activation of NMDA receptor induced a signiﬁcant increase of
ROS by 30% that is inhibited when the signaling in the NMDA-
PKC-NOX pathway is blocked by the PKC inhibitor G06893
(Figure 4B).
DISCUSSION
In this study we provide evidence supporting the idea that NMDA
stimulates oligodendrocyte differentiation via activation of PKC
(see also Figure 5). Oligodendrocyte differentiation from SVZ
multipotent stem cells is modulated by ﬁne tuned regulation of
NMDA receptor subtypes, especially by the expression of NR3
subunit (Cavaliere et al., 2012). SVZ multipotent cells express high
levels of NR3 with high NR3/NR1 ratio during proliferation but
after stimulating oligodendrocyte differentiation, the same ratio
revertswith higherNR1 expression respect toNR3 (Cavaliere et al.,
2012). This stoichiometry reveals a dominant negative role of the
NR3 subunit which has a low afﬁnity for glutamate but higher
afﬁnity for glycine (Yao and Mayer, 2006) resulting in a lack of
NMDA receptor function during proliferation. In SVZ oligoden-
drocytes differentiate from type C cells (transit amplifying cells).
Depending on the culture condition or environmental constraints,
type C cells can typically differentiate into neuroblasts, or alter-
natively into OPCs. In turn, we found that NMDA stimulates the
ﬁnal differentiation fromOPCs intomature oligodendrocytes. The
effect of NMDA during oligodendrocyte differentiation looks cell
speciﬁc since no signiﬁcant differences were observed in neuronal
and astrocytic differentiation.
As expected, overactivation of NMDA receptors can lead to
activation of PKC. When transfected with the luciferase reporter
gene, under the control of the AP1 promoter, differentiating
oligodendrocytes showed increased luciferase expression when
FIGURE 4 | (A) Neurospheres were differentiated to oligodendrocyte for
3–5 days in the presence of 100 μM NMDA, 100 nM G0 6983, or 1mM
gp91. Cells were ﬁxed, immunostained with anti-MBP and counterstained
with DAPI. Differentiation was calculated as a ratio between MBP positive
cells vs. total cells counterstained with DAPI and expressed as a fold
increase respect to the control. Counts represent means ± SEM (n = 4
independent experiments, ﬁve ﬁelds in each). ∗∗p < 0.01 vs. CTRL,
###p < 0.001 and ##p < 0.01 vs. 1 μM NMDA (B) ROS generation was
calculated by luminescence after 3 days of differentiation in the presence of
100 μM NMDA and the PKC inhibitor G0 6983. The PKC activator PMA was
used as a control for PKC-dependent ROS generation. Counts represent
means ± SEM (n = 4 independent experiments, ﬁve ﬁelds in each).
∗p < 0.05 and ∗∗p < 0.01 vs. CTRL, #p < 0.05 vs. 1 μM NMDA.
treated with NMDA (Figure 1A). These data were corroborated
also by a negative modulation of the PKC inhibitor G0 6983
on oligodendrocyte differentiation (Figure 1B). Extensive stim-
ulation of NMDA receptors induced the generation of ROS via
NOX stimulation through the activation of PKC, which ulti-
mately resulted in hippocampal neuronal death (Brennan et al.,
2009). Similarly, during oligodendrocyte differentiation, PKC
activation by overstimulation of NMDA receptors induces NOX
activation. SVZ multipotent cells express similar levels of mRNA
encoding NOX1, NOX2, and NOX4 (Figure 2A) and selective
inhibition of NOX activity by apocyanin and gp91, the spe-
ciﬁc inhibitor of NOX2 in the presence of NMDA (but not by
Dpi; Cavaliere et al., 2012 and Figure 3B) suggested that only
NOX2 can be involved in oligodendrocyte differentiation. Unlike
hippocampal neurons, the generation of NOX-dependent ROS
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FIGURE 5 | Schematic representation of the hypothetical NMDA
receptor-induced oligodendrocyte differentiation. High levels of
extracellular glutamate trigger NMDA receptor responses which activate
PKC/NOX/p67 signaling. Activated NOX generates intracellular ROS that in
parallel can set off PI3K/mTOR and/or ERK pathways to induce
oligodendrocyte differentiation.
did not induce oligodendrocyte death but acted as a second
messenger to stimulate progenitor differentiation as observed
by others (Le Belle et al., 2011; Li et al., 2013). Furthermore
treatment with NMDA during oligodendrocyte differentiation
generates an increase in ROS production in parallel with differ-
entiation, which is modulated by apocynin and gp91 (Cavaliere
et al., 2012 and Figure 3) and the speciﬁc NMDA antagonist
MK801.
CONCLUSION
Results obtained from our group and others provide evidence for
a mechanism by which mild excitotoxic insults promote oligoden-
drocyte differentiation derived from SVZ multipotent cells. These
insults elevate the levels of ROS naturally generated in multipo-
tent and pluripotent cells which act as a second messenger that
induces oligodendrocyte differentiation through a proposed dual
pathway (detailed in Figure 4). In one case, tumor suppressor
protein PTEN is inactivated (Coant et al., 2010; Le Belle et al.,
2011) and thus releases the blockade of the PI3/Akt/mTOR path-
way (Li et al., 2013). In parallel, higher ROS levels can directly
activate ERK pathway and stimulate differentiation as previously
described (Kishida et al., 2005). In addition, a thirdmechanismhas
been recently suggested by which NMDA receptor activation regu-
latesOPCmigration and further differentiation by coupling to and
activating the Tiam1/Rac1 pathway which is in turn is activated by
PKC (Xiao et al., 2013).
In summary, our results highlight a novel signaling pathway
directed by glutamate that drives oligodendrocyte development
from SVZ, and that can favor remyelination in demyelinating
diseases.
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